Global Tissue Microarray Market - 2022-2029
Description
Global Tissue Microarray Market - 2022-2029
Market Overview
Tissue Microarray Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 10% during the forecast period (2022-2029).
Tissue microarray is a high-throughput technology that accelerates and facilitates in situ analysis of tissue. Array-based technology provides a platform for molecular profiling disease genes and tissue, such as DNA and tissue array. Thousands of genes are already identified using microarray technology that may be associated with disease initiation, development, and progression. The identification of these genes has enhanced the process of lead discovery. Tissue microarray helps analyze thousands of tissue samples simultaneously using array format. The tissue microarray technique helps maintain the pace of the lead discovery process.
Market Dynamics
Technological advancement in the Tissue Microarray is expected to drive market growth.
PREMIER Biosoft is a group of computer scientists and biologists dedicated to accelerating research in life sciences. The company has developed Tissue Microarray Software for Data Analysis. For instance, TMA Foresight is a tissue microarray data analysis tool created to investigate the relationship between clinicopathological variables and the outcome and biomarker expression. Statistical methods like Cox Regression, Hierarchical Clustering, and Survival Analysis with Kaplan-Meier Survival Plots discover relevant biomarkers that affect the outcome and prognostically significant groupings of patients. Data pre-processing is made simple using TMA Foresight. The data can be categorized, changed, or ignored from a single screen. Depending on the measurement level selected, missing data can be filled in, guaranteeing the accuracy of the data for subsequent analysis.
Moreover, The link between the variables can be measured using correlation analysis. Determining the link between the number of copies of a gene and the expression of its protein helps validate cDNA microarray data. Using principal component analysis, you can examine multidimensional data collection. The patients can be grouped into prognostically relevant categories by reducing dimensionality. TMA Foresight is a helpful tool for pathologists, doctors, and researchers because it not only analyses the data but also interprets it. Thus, from the above statements, the market is expected to drive in the forecast period.
Restraint:
Alternative Techniques availability and high costs associated With the Microarray Technique are some factors the market is expected to hamper in the forecast period.
Industry Analysis
The tissue microarray market provides in-depth analysis of the market based on various industry factors such as porter’s five forces, supply chain, pricing analysis etc.
COVID-19 Impact Analysis
The COVID-19 pandemic has moderately impacted healthcare systems and the market. With the rapid development of diagnostics, expedited regulatory approvals, and increased distribution in many countries to help slow the spread of the virus, the COVID-19 pandemic has focused on the molecular diagnostics sector around the world. Moreover, the work supports and expands earlier findings and advances our knowledge of probable SARS-CoV-2 infection locations along the human respiratory tract. These findings show that the pandemic is driving a considerable demand for tissue microarray products. In Contrast, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of the economic activities.
Segment Analysis
Immunohistochemistry segment is expected to hold the largest market share in tissue microarray market
The immunohistochemistry segment is expected to dominate in 2021. The segment benefits from one of the most popular uses of immunostaining in immunohistochemistry. Utilizing the idea that antibodies attach particularly to antigens in biological tissues entails the technique of selectively detecting antigens in cells of a tissue segment. Moreover, an increase in cancer cases and product launches by the market players are some of the factors the market is expected to boost in the forecast period. For instance, Roche introduced the DISCOVERY Green HRP kit in March 2021. It is the most recent addition to the extensive array of modular-based detection kits used in tissue-based research to locate and profile cell populations and biomarkers. In addition, when combined with other detection kits, the green HRP (horseradish peroxidase) kit can increase the multiplexing capacity of both immunohistochemistry (IHC) and in situ hybridization (ISH) by offering a distinctive color that contrasts with other chromogens. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.
Geographical Analysis
North America region holds the largest market share in the global tissue microarray market
In 2021, North America accounted for the highest revenue share. The increasing prevalence of Cancer, well-established infrastructure, product launches and acquisitions by the key market players, increase in health care expenditure, and advanced technology adoption is some factors the market is expected to boost in the forecast period. For instance, according to the American Cancer Society, The number of new cancer cases and fatalities in 2022 is projected to have an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. In Contrast, in the United States, there will be 608,570 cancer deaths and an estimated 1.9 million newly diagnosed cancer cases in 2021. Moreover, In January 2022, Histobiolab, a division of Creative Bioarray, reported that it had developed a professional tissue microarray to meet precise research needs. Therefore, it has increased the demand for tissue microarray. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.
Competitive Landscape
Major key players in the tissue microarray market are Epredia, Novus Biologicals , OriGene Technologies, Inc, ProteoGenex, PREMIER Biosoft , BioIVT, 3DHISTECH Ltd, US Biomax Inc., CD Genomics, Ted Pella, Inc.
BioIVT:
Overview:
BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. The company specializes in control and disease state samples, including human and animal tissues, cell products, blood, and other biofluids. The company's unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. Moreover, when combined with other detection kits, the green HRP (horseradish peroxidase) kit can increase the multiplexing capacity of both immunohistochemistry (IHC) and in situ hybridization (ISH) by offering a distinctive color that contrasts with other chromogens. BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE.
Product Portfolio:
Cervical Cancer Tissue Microarray: Cervical Cancer Tissue Microarray represents 20 samples of cervical cancer with representative normal tissue (40 x 1.0mm cores, duplicate sampling).
The global tissue microarray’ market report would provide an access to an approx. 45+market data table, 40+figures and 200pages.
Market Overview
Tissue Microarray Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 10% during the forecast period (2022-2029).
Tissue microarray is a high-throughput technology that accelerates and facilitates in situ analysis of tissue. Array-based technology provides a platform for molecular profiling disease genes and tissue, such as DNA and tissue array. Thousands of genes are already identified using microarray technology that may be associated with disease initiation, development, and progression. The identification of these genes has enhanced the process of lead discovery. Tissue microarray helps analyze thousands of tissue samples simultaneously using array format. The tissue microarray technique helps maintain the pace of the lead discovery process.
Market Dynamics
Technological advancement in the Tissue Microarray is expected to drive market growth.
PREMIER Biosoft is a group of computer scientists and biologists dedicated to accelerating research in life sciences. The company has developed Tissue Microarray Software for Data Analysis. For instance, TMA Foresight is a tissue microarray data analysis tool created to investigate the relationship between clinicopathological variables and the outcome and biomarker expression. Statistical methods like Cox Regression, Hierarchical Clustering, and Survival Analysis with Kaplan-Meier Survival Plots discover relevant biomarkers that affect the outcome and prognostically significant groupings of patients. Data pre-processing is made simple using TMA Foresight. The data can be categorized, changed, or ignored from a single screen. Depending on the measurement level selected, missing data can be filled in, guaranteeing the accuracy of the data for subsequent analysis.
Moreover, The link between the variables can be measured using correlation analysis. Determining the link between the number of copies of a gene and the expression of its protein helps validate cDNA microarray data. Using principal component analysis, you can examine multidimensional data collection. The patients can be grouped into prognostically relevant categories by reducing dimensionality. TMA Foresight is a helpful tool for pathologists, doctors, and researchers because it not only analyses the data but also interprets it. Thus, from the above statements, the market is expected to drive in the forecast period.
Restraint:
Alternative Techniques availability and high costs associated With the Microarray Technique are some factors the market is expected to hamper in the forecast period.
Industry Analysis
The tissue microarray market provides in-depth analysis of the market based on various industry factors such as porter’s five forces, supply chain, pricing analysis etc.
COVID-19 Impact Analysis
The COVID-19 pandemic has moderately impacted healthcare systems and the market. With the rapid development of diagnostics, expedited regulatory approvals, and increased distribution in many countries to help slow the spread of the virus, the COVID-19 pandemic has focused on the molecular diagnostics sector around the world. Moreover, the work supports and expands earlier findings and advances our knowledge of probable SARS-CoV-2 infection locations along the human respiratory tract. These findings show that the pandemic is driving a considerable demand for tissue microarray products. In Contrast, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of the economic activities.
Segment Analysis
Immunohistochemistry segment is expected to hold the largest market share in tissue microarray market
The immunohistochemistry segment is expected to dominate in 2021. The segment benefits from one of the most popular uses of immunostaining in immunohistochemistry. Utilizing the idea that antibodies attach particularly to antigens in biological tissues entails the technique of selectively detecting antigens in cells of a tissue segment. Moreover, an increase in cancer cases and product launches by the market players are some of the factors the market is expected to boost in the forecast period. For instance, Roche introduced the DISCOVERY Green HRP kit in March 2021. It is the most recent addition to the extensive array of modular-based detection kits used in tissue-based research to locate and profile cell populations and biomarkers. In addition, when combined with other detection kits, the green HRP (horseradish peroxidase) kit can increase the multiplexing capacity of both immunohistochemistry (IHC) and in situ hybridization (ISH) by offering a distinctive color that contrasts with other chromogens. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.
Geographical Analysis
North America region holds the largest market share in the global tissue microarray market
In 2021, North America accounted for the highest revenue share. The increasing prevalence of Cancer, well-established infrastructure, product launches and acquisitions by the key market players, increase in health care expenditure, and advanced technology adoption is some factors the market is expected to boost in the forecast period. For instance, according to the American Cancer Society, The number of new cancer cases and fatalities in 2022 is projected to have an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. In Contrast, in the United States, there will be 608,570 cancer deaths and an estimated 1.9 million newly diagnosed cancer cases in 2021. Moreover, In January 2022, Histobiolab, a division of Creative Bioarray, reported that it had developed a professional tissue microarray to meet precise research needs. Therefore, it has increased the demand for tissue microarray. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.
Competitive Landscape
Major key players in the tissue microarray market are Epredia, Novus Biologicals , OriGene Technologies, Inc, ProteoGenex, PREMIER Biosoft , BioIVT, 3DHISTECH Ltd, US Biomax Inc., CD Genomics, Ted Pella, Inc.
BioIVT:
Overview:
BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. The company specializes in control and disease state samples, including human and animal tissues, cell products, blood, and other biofluids. The company's unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. Moreover, when combined with other detection kits, the green HRP (horseradish peroxidase) kit can increase the multiplexing capacity of both immunohistochemistry (IHC) and in situ hybridization (ISH) by offering a distinctive color that contrasts with other chromogens. BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE.
Product Portfolio:
Cervical Cancer Tissue Microarray: Cervical Cancer Tissue Microarray represents 20 samples of cervical cancer with representative normal tissue (40 x 1.0mm cores, duplicate sampling).
The global tissue microarray’ market report would provide an access to an approx. 45+market data table, 40+figures and 200pages.
Table of Contents
200 Pages
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Market Definition and Overview
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Market Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Technological advancement in the Tissue Microarray is expected to drive market growth.
- 4.1.2. Restraints:
- 4.1.2.1. Alternative Techniques availability and high costs associated With the Microarray Technique are some factors the market is expected to hamper in the forecast period.
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 5. Industry Analysis
- 5.1. Supply Chain Analysis
- 5.2. Pricing Analysis
- 5.3. Unmet Needs
- 6. COVID-19 Analysis
- 6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
- 6.2. Pricing Dynamics Amid Covid-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During Pandemic
- 6.5. Manufacturers Strategic Initiatives
- 6.6. Conclusion
- 7. By Procedure
- 7.1. Introduction
- 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 7.1.2. Market Attractiveness Index, By Procedure Segment
- 7.2. Immunohistochemistry*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
- 7.3. Fluorescent in Situ Hybridization
- 7.4. In Situ Hybridization
- 7.5. Frozen Tissue Array
- 7.6. Others
- 8. By Technology
- 8.1. Introduction
- 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
- 8.1.2. Market Attractiveness Index, By Technology Segment
- 8.2. DNA Microarray
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
- 8.3. Polymerase Chain Reaction (PCR)
- 8.4. Next-Generation Sequencing
- 8.5. Others
- 9. By Application
- 9.1. Introduction
- 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application Segment
- 9.2. Oncology*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
- 9.3. Gene Expression Profiling
- 9.4. Comparative Genomic Hybridization
- 9.5. SNP Detection
- 9.6. Double-Stranded B-DNA Microarrays
- 9.7. Sequencing Bioinformatics
- 9.8. Others
- 10. By End user
- 10.1. Introduction
- 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
- 10.1.2. Market Attractiveness Index, By End user Segment
- 10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
- 10.3. Pharmaceutical and Biotechnological Companies
- 10.4. Research Organization
- 10.5. Others
- 11. By Region
- 11.1. Introduction
- 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
- 11.1.2. Market Attractiveness Index, By Region
- 11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
- 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
- 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.2.7.1. U.S.
- 11.2.7.2. Canada
- 11.2.7.3. Mexico
- 11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
- 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
- 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.3.7.1. Germany
- 11.3.7.2. U.K.
- 11.3.7.3. France
- 11.3.7.4. Italy
- 11.3.7.5. Spain
- 11.3.7.6. Rest of Europe
- 11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
- 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
- 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.4.7.1. Brazil
- 11.4.7.2. Argentina
- 11.4.7.3. Rest of South America
- 11.5. Asia Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
- 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
- 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.5.7.1. China
- 11.5.7.2. India
- 11.5.7.3. Japan
- 11.5.7.4. Australia
- 11.5.7.5. Rest of Asia Pacific
- 11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
- 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
- 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
- 12. Competitive Landscape
- 12.1. Key Developments and Strategies
- 12.2. Company Share Analysis
- 12.3. Product Benchmarking
- 12.4. List of Key Companies to Watch
- 13. Company Profiles
- 13.1. Epredia*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Key Highlights
- 13.1.4. Financial Overview
- 13.2. Novus Biologicals
- 13.3. OriGene Technologies, Inc
- 13.4. ProteoGenex
- 13.5. PREMIER Biosoft
- 13.6. BioIVT
- 13.7. 3DHISTECH Ltd
- 13.8. US Biomax Inc.
- 13.9. CD Genomics
- 13.10. Ted Pella, Inc.
- LIST NOT EXHAUSTIVE
- 14. Global Tissue Microarray Market – DataM
- 14.1. Appendix
- 14.2. About Us and Applications
- 14.3. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
